Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IDXX | TMO | ISRG | EW | FMS |
| Company | Idexx Laboratories | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Fresenius Medical Care Ag ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 488.28 | 574.23 | 381.79 | 85.31 | 20.72 |
| High | 505.07 | 579.07 | 387.33 | 87.79 | 21.01 |
| Low | 488.28 | 572.50 | 380.69 | 85.01 | 20.69 |
| Last | 500.82 | 577.93 | 385.45 | 87.42 | 20.88 |
| Change | +13.75 | +4.29 | +5.08 | +2.33 | +0.20 |
| % Change | +2.82% | +0.75% | +1.34% | +2.74% | +0.97% |
| Volume | 546,500 | 1,513,300 | 882,100 | 3,421,900 | 371,700 |
| 20-Day Average Volume | 524,845 | 1,514,515 | 1,440,800 | 2,932,020 | 430,660 |
| Previous Close | 487.07 | 573.64 | 380.37 | 85.09 | 20.68 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 486.91 | 565.96 | 376.82 | 86.78 | 20.27 |
| 20-Day Raw Stochastic | 82.82% | 84.98% | 75.68% | 47.63% | 76.42% |
| 20-Day Relative Strength | 48.89% | 54.28% | 53.11% | 49.07% | 54.89% |
| Weighted Alpha | +1.76 | +13.16 | +29.08 | +4.76 | -7.32 |
| Today's Opinion | 40% Sell | 72% Buy | 72% Buy | 56% Buy | 40% Buy |
| Previous Opinion | 40% Sell | 56% Buy | 56% Buy | 40% Buy | 40% Buy |
| Last Month's Opinion | 8% Sell | 88% Buy | 80% Buy | 80% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.25% since 05/02/24 | +1.17% since 05/02/24 | +2.07% since 05/02/24 | +2.77% since 05/02/24 | -3.60% since 05/02/24 |
| Low | 473.80 on 05/06/24 | 565.34 on 05/07/24 | 378.87 on 05/03/24 | 84.81 on 05/06/24 | 19.69 on 05/07/24 |
| High | 505.07 on 05/09/24 | 579.84 on 05/03/24 | 389.78 on 05/07/24 | 87.79 on 05/09/24 | 21.57 on 05/03/24 |
| 1-Month | |||||
| %Chg | -3.65% since 04/09/24 | -1.91% since 04/09/24 | -1.41% since 04/09/24 | -6.05% since 04/09/24 | +8.52% since 04/09/24 |
| Low | 462.00 on 05/01/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 18.32 on 04/12/24 |
| High | 512.72 on 04/10/24 | 586.46 on 04/24/24 | 392.80 on 04/11/24 | 92.99 on 04/11/24 | 21.67 on 05/02/24 |
| 3-Month | |||||
| %Chg | -12.48% since 02/09/24 | +4.94% since 02/09/24 | -0.71% since 02/09/24 | +2.83% since 02/09/24 | +6.86% since 02/09/24 |
| Low | 462.00 on 05/01/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 18.32 on 04/12/24 |
| High | 583.39 on 03/01/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 21.67 on 05/02/24 |
| 6-Month | |||||
| %Chg | +19.60% since 11/09/23 | +30.09% since 11/09/23 | +41.50% since 11/09/23 | +35.22% since 11/09/23 | +22.25% since 11/09/23 |
| Low | 417.93 on 11/10/23 | 437.26 on 11/10/23 | 269.49 on 11/10/23 | 63.88 on 11/10/23 | 16.86 on 11/10/23 |
| High | 583.39 on 03/01/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 21.67 on 05/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 41,361,216 | 220,605,120 | 136,719,120 | 52,679,288 | 12,252,948 |
| Shares Outstanding, K | 82,587 | 381,716 | 354,700 | 602,600 | 586,827 |
| Annual Sales | 3,660,950,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 21,054,650,000 |
| Annual Net Income | 845,040,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 540,060,000 |
| Last Quarter Sales | 964,100,000 | 10,345,000,000 | 1,890,600,000 | 1,598,200,000 | 5,371,060,000 |
| Last Quarter Net Income | 235,580,000 | 1,327,000,000 | 544,900,000 | 351,900,000 | 202,510,000 |
| 60-Month Beta | 1.27 | 0.80 | 1.39 | 1.10 | 0.95 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.81 on 05/01/24 | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 0.36 on 05/07/24 |
| Latest Earnings Date | 05/01/24 | 04/24/24 | 04/18/24 | 04/25/24 | 05/14/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | 0.415 on 05/17/23 |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | 05/17/24 |
| Ratios | |||||
| Price/Earnings ttm | 47.15 | 26.53 | 81.28 | 33.37 | 14.16 |